4.13 USD
↗ 0.12 (2.99%)AT CLOSE (03:59 PM EDT)
Adial Pharmaceuticals, Inc (ADIL) trades at $3.98 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (150.6%) and a bullish Golden Cross on the moving averages. On the valuation side, ADIL appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 1, 2026.